Basic information Safety Supplier Related
ChemicalBook >  Product Catalog >  Pharmaceutical intermediates >  Heterocyclic compound >  Quinoline compounds >  6-BROMO-4-CHLOROQUINOLINE

6-BROMO-4-CHLOROQUINOLINE

Basic information Safety Supplier Related

6-BROMO-4-CHLOROQUINOLINE Basic information

Product Name:
6-BROMO-4-CHLOROQUINOLINE
Synonyms:
  • BUTTPARK 23\09-04
  • 4-CHLORO-6-BROMOQUINOLINE
  • 6-BROMO-4-CHLOROQUINOLINE
  • 6-Bromo-4-chloroquinoline ,98%
  • 6-Bromo-4-chloroquinoline ,97%
  • 6-Bromo-4-chloro-1-azanaphthalene
  • 4--6-broMinechlorinequinoline
  • Quinoline,6-bromo-4-chloro-
CAS:
65340-70-7
MF:
C9H5BrClN
MW:
242.5
Mol File:
65340-70-7.mol
More
Less

6-BROMO-4-CHLOROQUINOLINE Chemical Properties

Melting point:
110-112℃
Boiling point:
314.6±22.0 °C(Predicted)
Density 
1.673±0.06 g/cm3(Predicted)
storage temp. 
Keep in dark place,Sealed in dry,Room Temperature
solubility 
soluble in Toluene
form 
solid
pka
2.76±0.16(Predicted)
Appearance
White to light yellow Solid
InChI
InChI=1S/C9H5BrClN/c10-6-1-2-9-7(5-6)8(11)3-4-12-9/h1-5H
InChIKey
KJILYZMXTLCPDQ-UHFFFAOYSA-N
SMILES
N1C2C(=CC(Br)=CC=2)C(Cl)=CC=1
More
Less

Safety Information

Hazard Codes 
T
Risk Statements 
25-20/22
Safety Statements 
45-36/37
WGK Germany 
3
HazardClass 
IRRITANT
HS Code 
29334900
More
Less

6-BROMO-4-CHLOROQUINOLINE Usage And Synthesis

Chemical Properties

Light yellow to yellow powder

Uses

6-Bromo-4-chloroquinoline belongs to the class of heterocyclic compounds and has been used in the synthesis of other compounds, such as pharmaceuticals.

Synthesis

145369-94-4

65340-70-7

4.1.8 Synthesis of 6-bromo-4-chloroquinoline (11) To a 100 mL round bottom flask were sequentially added 6-bromo-4-hydroxyquinoline (10) (3.0 g, 13.45 mmol), phosphorus trichloride (20 mL) and N,N-dimethylformamide (0.5 mL). The reaction mixture was heated to reflux and stirred for 6 hours. After completion of the reaction, it was cooled to room temperature and the reaction mixture was slowly poured into ice water (100 mL) and stirring was continued for 1 hour. Subsequently, the pH of the mixture was adjusted with saturated aqueous sodium bicarbonate solution to 8. The reaction mixture was extracted with ethyl acetate, the organic phases were combined and dried with anhydrous sodium sulfate. The organic phase was concentrated under reduced pressure to give the title compound 6-bromo-4-chloroquinoline (11) (2.75 g, 11.36 mmol, 84% yield) as a white solid. 1H NMR (500 MHz, DMSO-d6) δ 8.87 (d, J = 4.5 Hz, 1H, Ar-H), 8.32 (d, J = 2.0 Hz, 1H, Ar-H), 8.03 (d, J = 9.0 Hz, 1H, Ar-H), 7.99 (dd, J = 9.0, 2.0 Hz, 1H, Ar-H), 7.82 (d, J = 4.5 Hz, 1H, Ar-H). ESI-MS: m/z = 242 [M + H]+.

References

[1] Patent: US2006/63805, 2006, A1. Location in patent: Page/Page column 9
[2] ChemMedChem, 2015, vol. 10, # 5, p. 836 - 849
[3] Patent: US2015/320727, 2015, A1. Location in patent: Paragraph 0557; 0558
[4] European Journal of Medicinal Chemistry, 2015, vol. 99, p. 36 - 50
[5] Patent: WO2006/132739, 2006, A2. Location in patent: Page/Page column 48

6-BROMO-4-CHLOROQUINOLINESupplier

HINOVA PHARMACEUTICALS INC. Gold
Tel
18244267397
Email
cxinghua127@163.com
Changzhou DongChen Pharmaceutical Co., Ltd. Gold
Tel
0519-88995800 13815038136
changzhoubaotuobiochemical&pharm、LTD. Gold
Tel
0519-13912326059 13912326059
Email
alona1979@163.com
Suqian Gaosai Biomedical Technology Co., Ltd Gold
Tel
15250728346
Email
465418843@qq.com
Anhui Shuangmai Intelligent Technology Co., LTD Gold
Tel
19956280676
Email
sales@nbinno.com